ABSTRACT Flock House Virus (family Nodaviridae, genus Alphanodavirus, FHV) was originally isolated from grass grubs Costelytra zealandica (White) (Coleoptera: Scarabaeidae) in New Zealand and belongs to a family of divided genome, plus-sense RNA insect viruses. FHV replicates in insects, a nematode, plants, and yeast. We previously reported replication of FHV in four genera of mosquitoes and expression of green ßuorescent protein in Aedes aegypti (L.) produced by an FHV-based vector. We report here that FHV multiplies vigorously in vivo in the malaria vectors Anopheles gambiae Giles and An. stephensi Liston and in vitro in a cell line derived from An. gambiae. In addition, FHV multiplies extensively in two other medically important insects, the tsetse ßy, Glossina morsitans morsitans Westwood, and the reduviid bug Rhodnius prolixus Stal, extending its host range to four orders of insects (Coleoptera, Lepidoptera, Diptera, and Hemiptera). The virus disseminates in all the major tissues of the insects studied. Anopheles and Glossina show mortality when FHV is injected at a dose above 10 4 plaque-forming units (pfu) or the virus accumulates to titer above 10 8 pfu. A lower dose (10 3 pfu) promotes more extensive virus multiplication and reduces mortality to Ͻ10%. No adverse effects are observed in Ae. aegypti, Culex pipiens pipiens L., and Armigeres subalbatus (Coquillett), when injected with a dose of up to 10 7 pfu. Mosquitoes orally fed with FHV exhibited slower virus growth rate with lower mortality. Our results indicate that FHV has uniquely broad insect host range and that the virus can be used to study virus host interactions in a variety of medically important insects.
Flock House virus (family Nodaviridae, genus Omegatetravirus, FHV) (Hendry 1991 , Ball and Johnson 1998 , Ball et al. 2000 ) is a positive-strand RNA virus of insect origin. The virus was originally isolated from the grass grub Costelytra zealandica (White) (Coleoptera: Scarabaeidae) in New Zealand (Scotti et al. 1983) . FHV crosses the kingdom barrier and replicates in plants (Selling et al. 1990 , Dasgupta et al. 2001 ) and yeast (Price et al. 1996) . FHV also replicates in the nematode Caenorhabditis elegans (Lu et al. 2005 ). In the laboratory, FHV is propagated in the larvae of the wax moth, Galleria mellonella (L.) and cultured Drosophila melanogaster (Meigen) cells (Scotti et al. 1983, Selling and Rueckert 1984) . FHV does not cause any cytopathic effect in mammalian cells or mammals and is not considered a human pathogen (Ball and Johnson 1998) .
FHV is the most extensively studied member of Nodaviridae, with the smallest genome of any positive strand RNA virus of animals. FHV consists of two genomic RNAs packaged into a single, nonenveloped, icosahedral virion. RNA1 (3.1 kb) encodes the viral polymerase (112 kDa) and RNA2 (1.4 kb) encodes the viral capsid protein precursor (43 kDa) that is subsequently cleaved to mature capsid protein. RNA1 is capable of independent replication, whereas the replication of RNA2 is RNA1 dependent (Gallagher et al. 1983) . Formation of progeny virus particles requires coinfection of cells by both RNAs. Autonomous replication of RNA1 and its robust capacity to synthesize viral RNAs and subgenomic RNA3 provides a promising approach to the ampliÞcation of heterologous RNAs in insect cells by using FHV-based expression vectors. Recently, protein B2, translated from subgenomic RNA3 has been characterized as an RNA interference-mediated host gene silencing suppressor in Drosophila cells, Nicotiana bentamiana plants (Li et al. 2002) , and C. elegans (Lu et al. 2005) .
The range of insect hosts for FHV has not been thoroughly explored. We are studying the growth of FHV in medically important insects to develop an FHV-based vector for gene expression in these insects and study the molecular interactions between hosts and pathogens. We previously reported that FHV replicates in four species of mosquitoes: Aedes aegypti (L.), Culex pipiens pipiens (L.), Armigeres subalbatus (Coquillett), and Anopheles gambiae Giles (the genetically selected strain 4arr) and the expression of GFP in Ae. aegypti by using an FHV-based vector (Dasgupta et al. 2003) . Our current study includes FHV growth in a different species of An. gambiae (wild-type strain G3) and in Anopheles stephensi Liston. We have compared the growth of FHV in all species of mosquitoes tested thus far and show that the virus growth is most vigorous in Anopheles species. Two cell lines derived from An. gambiae also support FHV replication. In addition, FHV multiplies extensively in two more insect species, the tsetse ßy, Glossina morsitans morsitans Westwood, and the reduviid bug Rhodnius prolixus Stal, extending the virus host range to four orders of insects (Coleoptera, Lepidoptera, Diptera, and Hemiptera). We observed Ͻ100-to Ͼ100,000-fold increases in the virus titers in 5Ð7 d after injecting different species of insects with FHV. The virus disseminated in the midgut, fat body, salivary gland, and head tissues of these insects. In An. gambiae, we also observed FHV dissemination in the ovary. FHV caused mortality in Anopheles and Glossina species when accumulated at high titers; however, a lower injection dose reduced pathogenicity without compromising virus growth rate. Our results demonstrate the potential of FHV for studying interactions of viruses with medically important insect hosts transmitting pathogens for malaria, African sleeping sickness, and Chagas disease.
Materials and Methods
Maintenance of Insects. Mosquitoes used in this study were Ae. aegypti (black-eye Liverpool strain), Cx. p. pipiens (Iowa State strain), Ar. subalbatus, An. gambiae (Plasmodium susceptible strains G3 and 4arr), and An. stephensi. Mosquitoes were reared according to described methods (Christensen and Sutherland 1984 , Gerberg et al. 1994 , Paskewitz et al. 1999 . Reduviids (R. prolixus) and tsetse ßies (G. m. morsitans) were maintained and injected according to published procedures (Moloo 1971 (Schneider 1972) and An. gambiae cells were grown at 26ЊC in SchneiderÕs insect cell media supplemented with 10 Ð15% fetal bovine serum and 1% antibiotic/antimycotic solution (SigmaAldrich, St. Louis, MO). FHV was propagated in DL1 cells, puriÞed by sucrose gradient centrifugation, and virus titer was determined by plaque assay on a monolayer of DL1 cells as described by Selling and Rueckert (1984) . FHV RNA was isolated from puriÞed virus by phenol extraction (Gallagher et al. 1983 ) and used for transfection of insect cells.
Infection and Transfection of Cultured Cells. We have tested FHV growth in two hemocyte-like cell lines derived from neonate An. gambiae larvae (Muller et al. 1999), 4a-3B and Sua1B , and compared these cells with DL1 cells. Virus growth was followed for 144 h postinfection with FHV or for 96 h posttransfection with FHV RNA. Brießy, cultured DL1, 4a-3B and Sua1B cells (2 ϫ 10 6 ) were infected with FHV at a multiplicity of infection equal to 1, in six-well plates (Schneemann and Marshall 1998) . Virus was added to monolayer of cells and attached for 1 h. The media containing unattached virus were then removed and replaced with fresh media and incubation continued at 26ЊC for 144 h. The same number of cells was transfected with 1 g of FHV RNA by using TransMessenger transfection kit (QIAGEN, Valencia, CA) following the manufacturerÕs protocol. Cells were incubated with RNA for 4 h, the media containing unattached viral RNA were removed, and the cells were washed with 1ϫ phosphate-buffered saline (PBS). Fresh media were added to the cells, and incubation was continued at 26ЊC up to 96 h. Virus was collected at increasing times after infection/transfection. For virus collection, cells were resuspended in media, treated with 0.1% NP-40 (nonionic detergent, SigmaAldrich), and pelleted by centrifugation. Virus concentrations in the supernatants were determined by plaque assay (Selling and Rueckert 1984) .
Infection of Insects by Injection. Supernatants from FHV-infected Drosophila cells were used as a source of virus to infect insects by injection. Virus dilutions were made in 50 mM MOPS [3-(N-morpholino) propane-sulfonic acid, pH 6.8] buffer for injecting Anopheles and in Aedes saline buffer (150 mM NaCl, 1 mM CaCl 2 , 2 mM KCl, and 1 mM NaHCO 3 , pH 7.0) for injecting all other mosquitoes. Virus inoculum was dispensed on to a ParaÞlm-wrapped slide, drawn into pulled capillary needles, and then injected intrathoracically into the hemocoel of cold-anesthetized adult mosquitoes placed vertically on a vacuum saddle (Beernsten and Christensen 1990) . Groups of 50 Ð 80 adult mosquitoes were injected each with 0.2Ð 0.5 l containing Ϸ3 ϫ 10 2 Ð3 ϫ 10 8 plaque-forming units (pfu) infectious virus and experiments were repeated three to Þve times. Adult tsetse ßies (groups of 25) were injected in the thoracic musculature with 10 3 Ð 10 5 pfu and reduviid bugs (adults and nymphs) were injected in the membrane separating the terminalia and the last abdominal segment with 3 ϫ 10 5 pfu virus. Per Os Infection of Insects. Supernatants from FHV-infected DL1 cells also were used to infect insects per os with Ϸ2.0 ϫ 10 5 Ð3.0 ϫ 10 8 pfu per individual. PuriÞed virus was diluted with an artiÞcial bloodmeal (Kogan 1990 ) and exposed to mosquitoes through a ParaÞlm membrane on a water-jacketed membrane feeder (Rutledge et al. 1964) . DeÞbrinated rabbit blood was used to dilute virus to feed Anopheles. Control insects were fed uninfected blood.
Larvae of Ae. aegypti and An. gambiae were infected by mixing FHV (10 6 pfu/ml) with the Tetramin Þsh food, used for larval growth (Christensen and Sutherland 1984) , and reared for 10 d until emergence as adults.
Detection of FHV. We monitored and compared the growth of FHV in whole insects and their tissues by using plaque assay of mosquitoes collected at speciÞed time points for 14 d after injection or per os infection. Live adult insects (pools of three to Þve mosquitoes and individual tsetse and reduviid) were collected at speciÞed days postinoculation (dpi) and stored at Ϫ20ЊC, when not assayed immediately. In addition, immunoßuorescent assays (IFA) of dissected tissues of live insects were performed to monitor dissemination patterns. To see whether blood feeding had any effect on tissue distribution, mosquitoes were injected with 3 ϫ 10 3 pfu FHV, maintained for 5 d, given a bloodmeal and collected for assay 24 h later.
Plaque Assay. Virus-exposed insects were washed with 1 ml of isotonic buffer (IB; 100 mM NaCl, 35 mM PIPES, 10 mM KCl, 1 mM MgCl 2 , and 1 mM CaCl 2 , pH 6.8) to remove any external virus and then homogenized in 100 l (per mosquito) or 500 l (per tsetse or reduviid) of IB in 1.5-ml tubes with pestles. Head, salivary gland, midgut, fat body, and ovary were dissected from exposed insects and homogenized in 10 l of IB. A maximum of Þve mosquitoes or tissues were pooled for each assay. Homogenates were centrifuged at 14,000 rpm for 5 min, and the supernatants were subjected to plaque assays after appropriate dilutions on a monolayer of DL1 cells (Selling and Rueckert 1984) . Brießy, 90 l of cells (8 ϫ 10 6 ) grown in SchneiderÕs insect cell medium (Schneider 1972) were added to 10 l of appropriately diluted insect or tissue homogenate and mixed with gentle shaking at room temperature for 1 h. Cells were then poured into tissue culture dishes (60-mm-diameter Corning polystyrene cell culture dishes) and after 1 h, when cells were attached to the bottom of the dishes, medium was replaced with an overlay of 1% agarose (low melting point, Seakem-LE agarose) in SchneiderÕs medium. Dishes were incubated at 26ЊC, and we visualized the plaques after 60 h by staining the cells black with 0.5 ml of 3 mg/ml solution of 3-(4,5,-dimethylthiazol-2-yl)-2,5,-diphenyl tetrazolium bromide (Sigma-Aldrich) in isotonic buffer. Plaques occurred as transparent small circles (2Ð3 mm in diameter). Each assay was performed with at least two dilutions. PuriÞed FHV was assayed in parallel as a positive control. Virus-infected tsetse and reduviids were homogenized individually and plaque assayed.
Immunofluorescent Assay. Tissues were dissected from An. gambiae, Ae. aegypti, tsetse, and reduviid, and dissemination of FHV was monitored using IFA (Cheng et al. 2001 ) as well as quantitatively by plaque assay (described above). Tissues from Þve to 10 mosquitoes, individual tsetse ßy, or reduviid bug were spread on poly-L-lysineÐ coated slides. Polyclonal anti-FHV antibody and ßuorescein isothiocyanate-labeled goat anti-rabbit IgG were used at dilutions of 1:400 and 1:800, respectively, as primary and secondary antibodies for virus detection by using IFA. The ßuorescence was examined in tissues using UV illumination on an Olympus IX70 inverted microscope.
Statistical Analysis. Mosquitoes were injected with FHV in groups of 50 Ð 80 per treatment per experiment, and experiments were repeated three to Þve times. To monitor growth and dissemination of FHV in mosquitoes, 5Ð15 mosquitoes were collected at speciÞed times for plaque assay. Mosquitoes were plaque assayed in pools of three to Þve, and titer/ individual was calculated. At least two pools were assayed for each treatment per experiment to calculate the average titer per mosquito for each experiment. The titers we have reported here are the average across replicate experiments of titer per mosquito. Similarly, FHV growth in tsetse and reduviid were calculated from the average titer found in up to 10 individuals for three replicate experiments. Mortality was calculated from the ratio of number dead to total number injected. Growth and dissemination of FHV in An. gambiae tissues were calculated by comparing the ratio of average virus titer per tissue to average titer per whole body. Percentage of FHV growth in each tissue was normalized by comparative weight (measured on a balance) of the dissected tissue. Cell line infection and transfection experiments were repeated two to Þve times, and averages were calculated from each replicate. Standard deviations and error bars were calculated using common formulas (Microsoft Excel; Ramsey and Schafer 2002) . Dasgupta et al. (2003) . As expected, Ae. aegypti, Cx. p. pipiens, and Ar. subalbatus injected with 2 ϫ 10 5 pfu FHV showed an initial drop in virus titer at 3 dpi. The titer began increasing at 5 dpi, peaked at 7 dpi, and leveled off afterward. There was about a 100-, 30-, and 10-fold increase (compared with the titer at 3 dpi) in FHV titer at 7 dpi in whole bodies of Ae. aegypti, Cx. p. pipiens, and Ar. subalbatus, respectively. Injection with higher doses (10 6 Ð10 8 pfu) did not enhance virus growth rate, and the titers still peaked at 2 ϫ 10 8 pfu and then reached a plateau. Virus did not multiply when injected with lower doses (10 3 and 10 4 pfu) in these three species of mosquitoes. Growth in Anopheles Species. We have previously reported FHV growth in An. gambiae 4arr (a genetically selected strain), injected with a dose of 2 ϫ 10 5 pfu showing about a 100-fold increase in virus titer at 7 dpi (Dasgupta et al. 2003) . Studies reported here were carried out with a wild-type strain of An. gambiae (G3). Interestingly, FHV multiplied at a higher rate when we monitored virus growth in this strain. There was a 500-fold increase in titer at 7 dpi when G3 was injected with 2 ϫ 10 5 pfu virus (Table 1) . Moreover, An. gambiae G3 supported the same extent of virus growth (Ϸ10 8 pfu) at 5 dpi when injected with lower virus doses (Table 1 and Fig. 1A ). For example, at a 100-fold lower injection dose (3 ϫ 10 3 pfu) the virus titer increased to Ϸ1,000-fold (3.7 ϫ 10 6 pfu) at 3 dpi and to 30,000-fold (1.0 ϫ 10 8 pfu) at 5 dpi. An. stephensi was less permissive to FHV growth in comparison to An. gambiae. In An. stephensi, FHV titer increased to Ϸ25-fold at 7 dpi when injected with 3 ϫ 10 5 pfu FHV and to 2,500-fold when injected with 3 ϫ 10 3 pfu virus (Table 1) . Virus growth exhibited a plateau or slight drop after 7 dpi in both Anopheles species we tested.
Results

FHV Growth after Injection in
Overall, FHV growth in Anopheles was Ͼ100 Ð1000-fold higher than its growth in Aedes, Culex, and Armigeres species. Moreover, there was no initial drop in the virus titer at three dpi in An. gambiae or An. stephensi.
Growth in Orally Fed Adult Mosquitoes and Larvae. FHV replicated in mosquitoes when orally fed with a bloodmeal containing FHV; however, we observed high variation (2Ð3 logs) in virus accumulation in replicate experiments (data not shown). We suspect this is a result of differences in feeding behavior of different mosquito species. Aedes, Culex, and Armigeres species did not show virus multiplication when fed with a virus dose below 3 ϫ 10 6 pfu. There was a 10 Ð100-fold lower accumulation of virus (compared with the data in Table 1 ) in An. gambiae at 7 d postfeeding, indicating that the virus takes longer and/or replicates poorly when administered orally. We were unable to detect an increase in virus titer from the Ae. aegypti and An. gambiae larvae we attempted to feed FHV.
Pathogenicity in Mosquitoes Due to FHV Infection. Injecting An. gambiae with a dose (3 ϫ 10 3 pfu) that allowed maximum growth of FHV showed no adverse effects for up to 5 dpi (Fig. 1) . At 7 dpi, mortality with this dose remained at less than 10%. A lower dose (3 ϫ 10 2 pfu) reduced mortality further, but the virus multiplied only 1,000-fold at 5 dpi (Fig. 1B) . FHV infection with doses 3 ϫ 10 4 pfu and above caused pathogenicity, resulting in almost 40 Ð100% mortality in 7Ð10 dpi (Fig. 1B) . We observed 100% mortality within 7 d after FHV titer reached 10 8 pfu per mosquito, independent of injection dose. This suggests, accumulation of Ͼ10 8 pfu FHV is lethal to An. gambiae G3. Parallel experiment with An. stephensi showed 45% mortality when injected with 2 ϫ 10 5 pfu, and the virus accumulated to a similar titer (1.6 ϫ 10 8 pfu). In both Anopheles species, the mortality increased after 5 dpi, although the virus titer dropped and leveled off at 7 dpi. Survivability of Ae. aegypti, Cx. p. pipiens, and Ar. subalbatus was much higher compared with Anopheles species. Less than 10% mortality due to FHV growth was observed when these three mosquitoes were injected with doses of 10 5 Ð10 7 pfu. Orally fed An. gambiae showed no mortality at a dose of 10 5 pfu FHV through 14 d postfeeding. When fed a dose of 10 6 pfu FHV, we observed only 10% mortality at 10 dpi. At 10 7 and 10 8 pfu feeding doses, the mortality reached to a maximum of 50% at 10 dpi. This suggests that when An. gambiae is orally infected with FHV, at least a 1,000-fold higher dose (compared with the injection dose of 3 ϫ 10 3 pfu) is required to cause mortality. This is consistent with the slower FHV growth when the virus is orally fed to mosquitoes.
Dissemination of FHV in Mosquitoes. Fig. 2 shows a dissemination pattern based on virus titers measured by plaque assays with different tissues of mosquitoes injected with 2 ϫ 10 3 pfu FHV and dissected at 6 dpi. Major virus accumulations occurred in the fat body and the head (7.6 ϫ 10 6 and 6.0 ϫ 10 6 pfu, respectively; the whole body accumulation was 1.0 ϫ 10 8 pfu). This suggests the nervous tissues (head) and an immune organ (fat body) are preferred sites for the replication and/or accumulation of FHV in Anopheles. There were also considerable virus accumulations in midgut, salivary glands and ovaries (4.0 ϫ 10 5 , 5.6 ϫ 10 5 , and 2.1 ϫ 10 5 pfu, respectively). We have previously reported dissemination of FHV in the midgut, fat body, and head of Ae. aegypti (Dasgupta et al. 2003) . Blood feeding of virus injected An. gambiae at 24 h before harvesting had no signiÞcant effect on the virus growth in any tissue. A maximum of 13% increase in titer due to blood feeding was observed in the ovary, fat body, midgut, and head had a 7Ð9% increase. 
Growth of FHV in Mosquito Cells in Cultures.
Growth curves in D. melanogaster (DL1) and An. gambiae (4a-3B and Sua-1B) cells after virus infection or viral RNA transfection are shown in Fig. 3 . Virus growth rate up to 24 h posttransfection in DL1 and 4a-3B cells was exponential and comparable with each other (Fig. 3A) . Sua 1B cells supported a 30-fold lower virus growth at 24 h compared with DL1 or 4a-3B. After 24 h, the virus continued to grow in DL1 cells, but the growth reached a plateau in Anopheles cells. At 48 and 72 h, FHV accumulation in 4a-3B was Ϸ100 Ð 1,000-fold less, respectively, compared with DL1 cells. A similar virus growth and accumulation pattern was observed upon infection of these cells with FHV at a multiplicity 1.0 (Fig. 3B ), although at 24 h postinfection, accumulation of FHV in 4a-3B cells was 60-fold less than that in DL1 cells. Virus titer in Sua 1B cells reached its peak at 48 Ð72 h. These results suggest that Anopheles cells 4a-3B and Sua-1B allow efÞcient RNA replication and virus multiplication and produce infectious FHV. An. gambiae cells however, are less permissive to virus proliferation at later stages. No cytopathic effect (cpe), e.g., rounding up or clumping, was observed in either of the two An. gambiae cell lines infected with FHV. Bailey et al. (1975) observed no cpe when Ae. aegypti and Ae. albopictus cell cultures were infected with Nodamura virus (NOV), type member of the Nodaviridae.
Growth and Pathogenicity of FHV in Tsetse Flies. The virus accumulated to high titers in tsetse ßies (G. m. morsitans) infected by both oral feeding and injection. In orally fed (5 ϫ 10 5 pfu) ßies, FHV titers increased 4,000-fold at 5 dpi and 65,000-fold at 7 dpi (compared with the titer at 3 dpi; Table 2 ). The virus persisted after 7 d, and there was a four-fold drop in titer at 10 dpi. No mortality was observed through 10 d after feeding, although the titer reached to 4.9 ϫ 10 8 pfu at 7 dpi.
FHV accumulation in the whole body was 30 Ð 60-fold higher in the injected ßies (Table 2) . Injection with a titer of 10 5 pfu showed no drop in virus titer at 3 dpi and an increase of Ϸ2000, 20,000, and 150,000-fold in the whole body at 3, 5, and 7 dpi, respectively. There was no initial drop of virus titer at 3 dpi. Immunoßuorescence assay with dissected tissues of FHV-injected ßies showed (Fig. 4 , in color online) accumulation and spread of virus in midgut and fat body at 7 and 10 dpi. Plaque assays with head tissues showed 32 and 25% virus accumulation (ratio of average titers in the head and the whole body at each dpi) in the heads of orally fed and injected ßies, respectively. Considering the weight of the head (10% of the whole body), this suggests that nervous tissue is a preferred site for FHV growth or accumulation in G. m. morsitans, similar to that observed in An. gambiae.
Flies showed only 10% mortality at 5 dpi after injection with 10 5 pfu FHV. At 7 dpi, 50% of injected ßies were dead and by 10 dpi, the mortality reached almost 100%. Injection with lower doses (3 ϫ 10 3 pfu) allowed enhanced replication (Þve-fold higher compared with injection with 3 ϫ 10 5 pfu) and low mortality (5Ð10%) at 5 dpi, similar to the pattern we observed with Anopheles.
Growth of FHV in Reduviid Bugs. The virus multiplied in all developmental stages, except Þrst and second instars of R. prolixus, and maximum accumulation was observed in Þfth instars and in adults. There was not a signiÞcant increase in FHV titer at 3 and 5 dpi (Þve and eight-fold, respectively), but the titer increased 3,000-fold in adults at 7 dpi (Table 3) . At 10 dpi, the virus growth reached a plateau, and there was only a 10% increase in titer at 14 dpi.
Tissue dissemination of FHV in R. prolixus is shown in Fig. 5 . Maximum accumulation of virus was found in the fat body and head at 7 dpi. At 10 dpi, the midgut and the salivary gland also showed considerable growth of FHV. The virus titer persisted in the head and fat body after 10 dpi; however, it dropped considerably in the midgut and salivary gland. Reduviid bugs showed 100% mortality at the Þrst and second nymphal stages and 40 Ð50% mortality at the third and fourth nymphal stages when injected with 2.4 ϫ 10 5 pfu. No mortality was observed at the Þfth instar or adult stages.
Discussion
Our data provide conclusive evidence that FHV, a virus of coleopteran origin, vigorously grows in three genera of medically important insects belonging to the orders Diptera and Hemiptera. In An. gambiae and G. m. morsitans, an injection dose of 3 ϫ 10 3 pfu FHV (Ϸ10 6 virus particles) was sufÞcient to initiate the infection process and allow the virus to replicate to optimum level in 5Ð7 dpi with minimum mortality. G. m. morsitans supported vigorous FHV growth when virus was administered both orally and by injection. The wide variation in the virus growth pattern we observed between different species and strains (for example, An. gambiae 4arr versus G3 strains) of the same genera are not surprising because virus infection and its transmission often follow speciÞc routes in nature. G3 is considered a wild-type strain, whereas 4arr is a genetically selected strain. Thus far, natural infection by FHV has only been reported in C. zealandica (Scotti et al., 1983) , and it would be interesting to see whether the insect species we studied are infected with FHV and vertically transmitted in nature.
Virus dose, rate of virus growth, and accumulation of virus in different tissues through time contributed to the pathogenicity of FHV. Enhanced growth in Anopheles and tsetse ßies at lower injection doses clearly indicates that inoculation with higher doses caused a retardation of virus growth due to pathogenicity. Mortality rates were higher in mosquitoes after seven dpi when the mosquitoes were older. Therefore, mortality could be an effect of aging and virus pathogenicity that makes it difÞcult to establish a clear relationship between dose, virus growth time, and mortality. Although mosquito pathogenicity due to FHV growth was not reported previously, Bailey and Scott (1973) and Tesh (1980) observed the multiplication and pathogenicity of NOV in mosquitoes. NOV is the only member of the Nodaviridae known to be pathogenic to both insects and mammals (Ball and Johnson 1998) . NOV multiplied and caused paralysis and death at 6 Ð10 dpi when injected intrathoracially into Ae. albopictus and Toxorhynchites amboinensis (Doleschall). Consistent with our observation, Tesh (1980) reported no mortality when Ae. albopictus was orally infected with NOV, even though the virus accumulated to the same levels as when injected. It is Reduviid bugs were injected with 2.4 ϫ 10 5 pfu FHV at the developmental stages indicated. Second instar, 6.1 Ϯ 0.6 6. Plaque assays were performed on individuals collected at 7 dpi.
a Average titer of 10 bugs in each replicate of 3 replicates (total n ϭ 30). possible that the pathogenicity of the virus or the kinetics of infection differ by the route of infection. In oral infection, the virus enters into the midgut Þrst and proteolytic enzymes in the midgut may cause partial degradation of the viral coat protein. When injected, the virus enters directly into the hemolymph and can disseminate into different tissues without going through the midgut and the digestive system. FHV disseminated to all the major tissues of insects we studied. A combination of plaque assay and IFA helped in our quantitation of virus accumulations in tissues. Vigorous accumulation of FHV in heads of all insects we studied is consistent with the observation of Tesh (1980) reporting that head squashes of Ae. albopictus, Tr. Amboinensis, and Cx. quinquefascitus mosquitoes infected with NOV contained large amounts of virus antigen as measured by IFA. No previous data are available on tissue dissemination of FHV in infected Anopheles species, tsetse, or reduviid.
Replication of FHV in Anopheles cell lines opens up the possibility of using FHV for in vitro studies such as differential gene expression after viral infection of insects. Cloned An. gambiae cell lines supporting enhanced FHV growth can be developed as previously reported with cell lines derived from Ae. albopictus (C6/36; Dasgupta et al. 2003) . Stably transformed cell lines harboring FHV replicon also may be developed for high-level expression of insect genes of interest. Mosquito cell cultures supporting replication of alphaviruses (such as Sindbis virus and Semliki Forest virus) and bunyaviruses (such as La Crosse virus) have been found useful for such purposes (Fallon and Sun, 2001, Kempf et al., 2006) . Viral expression vectors based on alphaviruses such as Sindbis virus, Semliki Forest virus, OÕnyong-nyong virus (Brault et al. 2004 , Chikingunya virus (Vanlandingham et al. 2005) , and densonucleosis viruses (Afanasiev and Carlson 2000) are continuously being developed and used to study mosquito gene functions. Each of these viruses has its own limitations in host range and tissue speciÞcities, and most of them are pathogenic to humans. None of the above-mentioned viruses are known to multiply in tsetse or reduviids. FHV-based vectors, therefore, will have additional advantages over the existing insect virus-based vectors. The ability of FHV to multiply and adapt in insects of different orders implies that the host components required for FHV replication and virus assembly are present in the tested hosts. We have shown the potential of FHV to express foreign genes in mosquitoes (Dasgupta et al. 2003) . Although FHV accumulation at high titers causes mortality in Anopheles or Glossina species, the virus titer before the onset of mortality increases to a level comparable with the maximum growth attained by alphaviruses (Bowers et al. 1995 , Higgs et al. 1999 , currently used for gene expression in mosquitoes. Mortality of FHV to insects therefore should not impose a limitation with gene expression using FHV-based vector. Small genome, wide host range, and nonpathogenicity of FHV make it an ideal candidate for developing an efÞcient gene expression vector in insects that transmit pathogens causing malaria, African sleeping sickness, and ChagaÕs disease.
